Al-Karmalawy AA - Search Results

1

Investigating the superiority of chitosan/D-alpha-tocopheryl polyethylene glycol succinate binary coated bilosomes in promoting the cellular uptake and anti-SARS-CoV-2 activity of polyphenolic herbal drug candidate.

Zakaria MY, Sharaky M, Noreddin AM, Alnajjar R, El-Shesheny R, Kutkat O, El-Beeh ME, Abourehab MAS, Al-Karmalawy AA. Zakaria MY, et al. Int J Pharm. 2023 Nov 5;646:123385. doi: 10.1016/j.ijpharm.2023.123385. Epub 2023 Sep 9. Int J Pharm. 2023. PMID: 37678473

2

Potential Valorization of Edible Nuts By-Products: Exploring the Immune-Modulatory and Antioxidants Effects of Selected Nut Shells Extracts in Relation to Their Metabolic Profiles.

Salem MA, Aborehab NM, Al-Karmalawy AA, Fernie AR, Alseekh S, Ezzat SM. Salem MA, et al. Antioxidants (Basel). 2022 Feb 25;11(3):462. doi: 10.3390/antiox11030462. Antioxidants (Basel). 2022. PMID: 35326112 Free PMC article.

3

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.

El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Elkaeed EB, Al-Karmalawy AA, Bahaa MM. El-Haggar SM, et al. J Inflamm Res. 2022 Feb 19;15:1159-1172. doi: 10.2147/JIR.S346608. eCollection 2022. J Inflamm Res. 2022. PMID: 35221706 Free PMC article. Retracted.

4

Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease.

Alnajjar R, Mostafa A, Kandeil A, Al-Karmalawy AA. Alnajjar R, et al. Heliyon. 2020 Dec;6(12):e05641. doi: 10.1016/j.heliyon.2020.e05641. Epub 2020 Dec 3. Heliyon. 2020. PMID: 33294721 Free PMC article.

5

Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate.

Soltane R, Chrouda A, Mostafa A, Al-Karmalawy AA, Chouaïb K, Dhahri A, Pashameah RA, Alasiri A, Kutkat O, Shehata M, Jannet HB, Gharbi J, Ali MA. Soltane R, et al. Pathogens. 2021 May 19;10(5):623. doi: 10.3390/pathogens10050623. Pathogens. 2021. PMID: 34069460 Free PMC article.

6

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2.

Kandeil A, Mostafa A, Kutkat O, Moatasim Y, Al-Karmalawy AA, Rashad AA, Kayed AE, Kayed AE, El-Shesheny R, Kayali G, Ali MA. Kandeil A, et al. Pathogens. 2021 Jun 15;10(6):758. doi: 10.3390/pathogens10060758. Pathogens. 2021. PMID: 34203977 Free PMC article.

7

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies.

Mahmoud DB, Ismail WM, Moatasim Y, Kutkat O, ElMeshad AN, Ezzat SM, El Deeb KS, El-Fishawy AM, Gomaa MR, Kandeil A, Al-Karmalawy AA, Ali MA, Mostafa A. Mahmoud DB, et al. J Drug Deliv Sci Technol. 2021 Dec;66:102845. doi: 10.1016/j.jddst.2021.102845. Epub 2021 Sep 15. J Drug Deliv Sci Technol. 2021. PMID: 34539819 Free PMC article.

8

In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus.

Elebeedy D, Badawy I, Elmaaty AA, Saleh MM, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Abd El Maksoud AI, Al-Karmalawy AA. Elebeedy D, et al. Comput Biol Med. 2022 Feb;141:105149. doi: 10.1016/j.compbiomed.2021.105149. Epub 2021 Dec 17. Comput Biol Med. 2022. PMID: 34953359

9

Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study.

Elmaaty AA, Alnajjar R, Hamed MIA, Khattab M, Khalifa MM, Al-Karmalawy AA. Elmaaty AA, et al. RSC Adv. 2021 Mar 9;11(17):10027-10042. doi: 10.1039/d0ra10674g. eCollection 2021 Mar 5. RSC Adv. 2021. PMID: 35423530 Free PMC article.

10

Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights.

Elebeedy D, Elkhatib WF, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Saleh MA, Abd El Maksoud AI, Badawy I, Al-Karmalawy AA. Elebeedy D, et al. RSC Adv. 2021 Sep 1;11(47):29267-29286. doi: 10.1039/d1ra05268c. eCollection 2021 Sep 1. RSC Adv. 2021. PMID: 35492070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page